Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC)
NCT07487805
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor, Adult
Interventions
DRUG:
Intermediate-dose ivermectin
DRUG:
High-dose ivermectin
Sponsor
University of Florida